Evidence map›Paper›PMID 41634932›Full record

ArticleMolecular biology and evolution2026

Invasion preferences suggest a possible role for Plasmodium falciparum parasites in the expansion of Duffy negativity in West and Central Africa.

Balanding Manneh, Viola Introini, James Reed, Madalina Rotariu, Robin Antrobus, Pietro Cicuta, Michael P Weekes, Bridget S Penman, Julian C Rayner

Abstract read
In one paragraph

Article in Molecular biology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Balanding MannehCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0009-0003-5391-6442
Viola IntroiniCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0001-9012-4696
James ReedResearch Donors, London, UK.ORCID 0009-0001-4441-9909
Madalina RotariuResearch Donors, London, UK.ORCID 0009-0000-2832-2149
Robin AntrobusCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0001-8608-4011
Pietro CicutaCavendish Laboratory, University of Cambridge, Cambridge, UK.ORCID 0000-0002-9193-8496
Michael P WeekesCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0003-3196-5545
Bridget S PenmanDepartment of Biology, University of Oxford, Oxford, UK.ORCID 0000-0001-9803-5209
Julian C RaynerCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0002-9835-1014

Funding

Bill & Melinda Gates FoundationCicuta groupCIMRGates Cambridge TrustGrand Challenges in Global Health InitiativeMalariaGENNIH HHS 566Rayner labUniversity of OxfordWeekes LabWellcome Senior Clinical Research Fellowship 108070/Z/15/ZWellcome Trust 220266/Z/20/ZWellcome Trust WT077383/Z/05/Z
6 · The paper itself

Abstract

Duffy antigen receptor for chemokines (DARC) is the primary red blood cell (RBC) receptor for invasion of human RBCs by Plasmodium vivax and Plasmodium knowlesi parasites. By contrast, Plasmodium falciparum parasites use multiple RBC receptors for invasion. Whether DARC is one of these receptors has never been systematically explored. We used flow cytometry and microscopy-based approaches to investigate whether P. falciparum parasites preferentially invade specific Duffy RBC phenotypes and explored 2 potential explanations for invasion preference-differences in RBC biophysical properties and surface protein composition. P. falciparum parasites showed a consistent preference for Duffy-positive RBCs, and some biophysical properties and surface protein expression varied between Duffy-positive and Duffy-negative RBCs. We then used our in vitro invasion data to parametrize an evolutionary-epidemiological model of the relationship between P. falciparum and the FYBES allele. Our model accounts for immunity against P. falciparum virulence, gained through exposure, and thus mutations that impede infection are not always advantageous. The inhibition of P. falciparum invasion that we observed in vitro leads to FYBES frequencies increasing at low levels of P. falciparum transmission but decreasing at high levels of transmission. The impact of P. falciparum on the prevalence of Duffy negativity may therefore be most apparent in lower transmission settings. Our findings show a link between Duffy negativity and P. falciparum and suggest that DARC may directly or indirectly be involved in P. falciparum invasion of human RBCs which could, together with P. vivax, explain the distribution of Duffy negativity in sub-Saharan Africa.

Indexed as

Duffy Blood-Group SystemErythrocytesMalaria, FalciparumPlasmodium falciparumReceptors, Cell SurfaceHumansACKR1 protein, humanDuffy Blood-Group SystemReceptors, Cell SurfaceDuffy Antigen Receptor for Chemokines (DARC)Duffy negativityerythrocyte invasionhost-pathogen coevolutionPlasmodium falciparumPlasmodium vivaxsingle nucleotide polymorphisms (SNPs)

Identifiers

PMID41634932
PMCPMC12930091

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.